Babar Ghias serves as Executive at BIOCRYST PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Babar Ghias has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 17, 2025 involved receiving (via award) 121,700 shares valued at $0.
Babar Ghias currently holds 268,700 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Babar Ghias has been a net neutral trader of BCRX stock. They have purchased $0 and sold $0 worth of shares.
Babar Ghias's most recent insider trade was on Dec 17, 2025, when they sold 121,700 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |